|
Survival groups
|
Scores
|
No. of cases
|
Survival period
|
Hazard ratio
|
Sig†
|
|---|
| |
Mean (95% CI)
|
Median (95% CI)
| | |
|---|
|
Tokuhashi
|
Original
|
1
|
12-15
|
12
|
37.1 (18.9 - 55.3)
|
17.1 (5.9 - 28.2)
|
-
|
0.000
|
|
2
|
9-11
|
21
|
32.8 (18.6 - 47.0)
|
10.7 (9.1 - 12.3)
|
1.23
|
0.654
|
|
3
|
0-8
|
79
|
9.4 (6.6 - 12.3)
|
5.3 (4.4 - 6.1)
|
3.17
|
0.004
|
|
Adjusted
|
1
|
12-15
|
14
|
38.3 (21.6 - 54.9)
|
17.1 (5.0 - 29.1)
|
-
|
0.000
|
|
2
|
9-11
|
27
|
26.9 (15.1 - 38.8)
|
8.9 (3.0 - 14.8)
|
1.67
|
0.222
|
|
3
|
0-8
|
71
|
9.0 (6.1 - 11.9)
|
4.9 (4.1 - 5.6)
|
3.56
|
0.001
|
|
Regrouped
|
1*
|
10-15
|
31
|
36.5 (24.9 - 48.1)
|
14.9 (5.3 - 24.5)
|
-
|
0.000
|
|
2*
|
6-9
|
47
|
12.9 (8.4 - 17.3)
|
6.2 (4.6 - 7.8)
|
2.42
|
0.002
|
|
3*
|
0-5
|
34
|
4.4 (3.3 - 5.5)
|
3.9 (2.1 - 5.8)
|
6.17
|
0.000
|
|
Tomita
|
Original
|
1
|
2-3
|
12
|
53.6 (36.3 - 70.8)
|
N/A
|
-
|
0.000
|
|
2
|
4-5
|
31
|
27.0 (16.2 - 37.8)
|
10.0 (7.7 - 12.4)
|
3.30
|
0.028
|
|
3
|
6-7
|
40
|
9.0 (5.7 - 12.4)
|
5.3 (4.4 - 6.1)
|
6.96
|
0.000
|
|
4
|
8-10
|
29
|
4.6 (3.2 - 6.0)
|
3.3 (2.2 - 4.5)
|
12.65
|
0.000
|
|
Regrouped
|
1*
|
2-3
|
12
|
53.6 (36.3 - 70.8)
|
N/A
|
-
|
0.000
|
|
2*
|
4-5
|
31
|
27.0 (16.2 - 37.8)
|
10.0 (7.7 - 12.4)
|
3.33
|
0.027
|
|
3*
|
6-8
|
57
|
8.2 (5.7 - 10.6)
|
5.5 (4.5 - 6.5)
|
7.65
|
0.000
|
| | |
4*
|
9-10
|
12
|
2.4 (1.7 - 3.1)
|
2.3 (1.7 - 2.9)
|
42.62
|
0.000
|
- *Reclassified groups after reorganization of prognostic scores. †P-value obtained by Cox regression; P <0.050 denotes statistical significance (Sig) N/A, estimation data not available due to the lack of uncensored cases. Dash means no value for parameter.
